LOGIN  |  REGISTER
Astria Therapeutics
C4 Therapeutics

LifeMD to Participate in Two Investor Conferences in October

September 27, 2023 | Last Trade: US$3.84 0.00 0.00

NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in two upcoming investor conferences in October.

  • LD Micro Main Event XVI Conference, October 3-5, 2023 at the Luxe Sunset Boulevard Hotel in Los Angeles. Management will deliver a company presentation on Tuesday, October 3rd at 3:30 p.m. Pacific time and will be available for one-on-one meetings. Investors can register to watch the presentation here.
  • Maxim Group 2023 Virtual Tech Conference Series: Exploring All Corners of the Tech Sector, October 10-11, 2023. Management will participate in a virtual fireside chat on Tuesday, October 10th at 3:30 p.m. Eastern Time. Investors can register for the conference here.

About LifeMD, Inc.

LifeMD is a leading provider of virtual primary care. LifeMD offers telemedicine, laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s health, women’s health, allergy & asthma, and dermatology. Leveraging a vertically-integrated, proprietary digital care platform, a 50-state affiliated medical group, and a US-based patient care center, LifeMD is elevating healthcare by increasing access to top-notch and affordable care. For more information, please visit LifeMD.com.

Company Contact
LifeMD, Inc.
Marc Benathen, CFO
This email address is being protected from spambots. You need JavaScript enabled to view it.

Media Contact
This email address is being protected from spambots. You need JavaScript enabled to view it.

C4 Therapeutics

Stock Quote

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page